Molluscum contagiosum affects an estimated 6 million Americans each year, predominantly children between the ages of 1 and 10. Despite two FDA approvals since 2023, a meaningful clinical gap remains and the practice patterns that have long defined pediatric MC management have not yet caught up with the science.

Latin American dermatology sites offer some of the fastest enrollment timelines in the world, but data quality concerns have kept many sponsors on the sidelines. Read Precefi's position paper to learn why Latin America is no longer a risk to be managed, but an advantage to be leveraged.